Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Feb;38(2):271-6.
doi: 10.2337/dc14-1813. Epub 2014 Dec 17.

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Collaborators, Affiliations
Observational Study

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Jay M Sosenko et al. Diabetes Care. 2015 Feb.

Abstract

Objective: We assessed whether type 1 diabetes (T1D) can be diagnosed earlier using a new approach based on prediction and natural history in autoantibody-positive individuals.

Research design and methods: Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Natural History Study (TNNHS) participants were studied. A metabolic index, the T1D Diagnostic Index60 (Index60), was developed from 2-h oral glucose tolerance tests (OGTTs) using the log fasting C-peptide, 60-min C-peptide, and 60-min glucose. OGTTs with Index60 ≥2.00 and 2-h glucose <200 mg/dL (Ind60+Only) were compared with Index60 <2.00 and 2-h glucose ≥200 mg/dL (2hglu+Only) OGTTs as criteria for T1D. Individuals were assessed for C-peptide loss from the first Ind60+Only OGTT to diagnosis.

Results: Areas under receiver operating characteristic curves were significantly higher for Index60 than for the 2-h glucose (P < 0.001 for both DPT-1 and the TNNHS). As a diagnostic criterion, sensitivity was higher for Ind60+Only than for 2hglu+Only (0.44 vs. 0.15 in DPT-1; 0.26 vs. 0.17 in the TNNHS) OGTTs. Specificity was somewhat higher for 2hglu+Only OGTTs in DPT-1 (0.97 vs. 0.91) but equivalent in the TNNHS (0.98 for both). Positive and negative predictive values were higher for Ind60+Only OGTTs in both studies. Postchallenge C-peptide levels declined significantly at each OGTT time point from the first Ind60+Only OGTT to the time of standard diagnosis (range -22 to -34% in DPT-1 and -14 to -27% in the TNNHS). C-peptide and glucose patterns differed markedly between Ind60+Only and 2hglu+Only OGTTs.

Conclusions: An approach based on prediction and natural history appears to have utility for diagnosing T1D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Shown are mean C-peptide levels from the first Ind60+Only OGTT exceeded during follow-up to diagnosis in DPT-1. There was a marked decline in C-peptide levels at each of the postchallenge time points.
Figure 2
Figure 2
Panel A shows mean C-peptide levels for time points of Ind60+Only OGTTs and 2hglu+Only OGTTs in DPT-1. The C-peptide levels of the Ind60+Only OGTTs were much lower. Panel B shows mean glucose values for time points of Ind60+Only OGTTs and 2hglu+Only OGTTs in DPT-1. The glucose values tended to be higher at the earlier time points in the Ind60+Only OGTTs and higher at the later OGTT time points in the 2hglu+Only OGTTs.

References

    1. American Diabetes Association . Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl. 1):S81–S90 - PubMed
    1. Rosenbloom AL, Hunt SS, Rosenbloom EK, Maclaren NK. Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes. Diabetes 1982;31:385–387 - PubMed
    1. Tarn AC, Smith CP, Spencer KM, Bottazzo GF, Gale EAM. Type I (insulin dependent) diabetes: a disease of slow clinical onset? Br Med J (Clin Res Ed) 1987;294:342–345 - PMC - PubMed
    1. Beer SF, Heaton DA, Alberti KG, Pyke DA, Leslie RD. Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins. Diabetologia 1990;33:497–502 - PubMed
    1. Sosenko JM, Krischer JP, Palmer JP, et al. Diabetes Prevention Trial-Type 1 Study Group . A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2008;31:528–533 - PubMed

Publication types